Skip to main content

ACRX Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

AcelRx Pharmaceuticals Inc. News

Here's Why AcelRx Pharmaceuticals (ACRX) Stock Gained Today

AcelRx Pharmaceuticals (ACRX) announced on Thursday that ARX-04, its experimental pain relief drug, had positive results in a phase III clinical trial.

AcelRx Pharmaceuticals (ACRX) Highlighted As Weak On High Volume

Trade-Ideas LLC identified AcelRx Pharmaceuticals (ACRX) as a weak on high relative volume candidate

AcelRx Pharmaceuticals (ACRX) Strong On High Relative Volume Today

Trade-Ideas LLC identified AcelRx Pharmaceuticals (ACRX) as a strong on high relative volume candidate

Amicus, Other Biotech CEOs Should Listen More, Talk Less About FDA Matters

There's a valuable, albeit painful, lesson here in Amicus' blow-up. Biotech CEOs should shut their mouths about regulatory plans until they receive definitive word from the FDA.

5 Stocks Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

Breaking News

Ford Makes a Major Change

The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Summers, Others Cite Growing Chance of Recession

GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.